J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways

Johnson & Johnson's quarter was imperfect, but enough is going right to validate our ownership of the stock.

Summary aggregated from CNBC's public RSS feed. The full reporting belongs to CNBC — please read it on their site.